151 related articles for article (PubMed ID: 33662456)
1. Oxygen and oxaliplatin-loaded nanoparticles combined with photo-sonodynamic inducing enhanced immunogenic cell death in syngeneic mouse models of ovarian cancer.
Zheng J; Sun J; Chen J; Zhu S; Chen S; Liu Y; Hao L; Wang Z; Chang S
J Control Release; 2021 Apr; 332():448-459. PubMed ID: 33662456
[TBL] [Abstract][Full Text] [Related]
2. The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells.
Xie W; Zhu S; Yang B; Chen C; Chen S; Liu Y; Nie X; Hao L; Wang Z; Sun J; Chang S
Int J Nanomedicine; 2019; 14():9377-9393. PubMed ID: 31819438
[TBL] [Abstract][Full Text] [Related]
3. Photo-sonodynamic therapy mediated with OLI_NPs to induce HPV16E7-specific immune response and inhibit cervical cancer in a Tc-1-grafted murine model.
Zhao G; Chen S; Zheng J; Li C; Zhong X; Cao Y; Zheng Y; Sun J; Zhu S; Chang S
J Photochem Photobiol B; 2023 Jan; 238():112583. PubMed ID: 36436360
[TBL] [Abstract][Full Text] [Related]
4. Folate-Targeted and Oxygen/Indocyanine Green-Loaded Lipid Nanoparticles for Dual-Mode Imaging and Photo-sonodynamic/Photothermal Therapy of Ovarian Cancer in Vitro and in Vivo.
Liu Y; Chen S; Sun J; Zhu S; Chen C; Xie W; Zheng J; Zhu Y; Xiao L; Hao L; Wang Z; Chang S
Mol Pharm; 2019 Oct; 16(10):4104-4120. PubMed ID: 31517495
[TBL] [Abstract][Full Text] [Related]
5. Dual-mode imaging and therapeutic effects of drug-loaded phase-transition nanoparticles combined with near-infrared laser and low-intensity ultrasound on ovarian cancer.
Chen S; Liu Y; Zhu S; Chen C; Xie W; Xiao L; Zhu Y; Hao L; Wang Z; Sun J; Chang S
Drug Deliv; 2018 Nov; 25(1):1683-1693. PubMed ID: 30343601
[TBL] [Abstract][Full Text] [Related]
6. Oxygen and indocyanine green loaded phase-transition nanoparticle-mediated photo-sonodynamic cytotoxic effects on rheumatoid arthritis fibroblast-like synoviocytes.
Tang Q; Cui J; Tian Z; Sun J; Wang Z; Chang S; Zhu S
Int J Nanomedicine; 2017; 12():381-393. PubMed ID: 28123298
[TBL] [Abstract][Full Text] [Related]
7. Engineering oxygen-deficient ZrO
Jiao X; Sun L; Zhang W; Ren J; Zhang L; Cao Y; Xu Z; Kang Y; Xue P
Biomaterials; 2021 May; 272():120787. PubMed ID: 33819815
[TBL] [Abstract][Full Text] [Related]
8. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.
Zhang Y; Guo C; Liu L; Xu J; Jiang H; Li D; Lan J; Li J; Yang J; Tu Q; Sun X; Alamgir M; Chen X; Shen G; Zhu J; Tao J
Theranostics; 2020; 10(24):11197-11214. PubMed ID: 33042278
[No Abstract] [Full Text] [Related]
9. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
[TBL] [Abstract][Full Text] [Related]
10. The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death.
Duan XC; Peng LY; Yao X; Xu MQ; Li H; Zhang SQ; Li ZY; Wang JR; Feng ZH; Wang GX; Liao A; Chen Y; Zhang X
Drug Deliv; 2021 Dec; 28(1):800-813. PubMed ID: 33866918
[TBL] [Abstract][Full Text] [Related]
11. Photoacoustic mediated multifunctional tumor antigen trapping nanoparticles inhibit the recurrence and metastasis of ovarian cancer by enhancing tumor immunogenicity.
Zhong X; Li C; Zhao G; Li M; Chen S; Cao Y; Wang Q; Sun J; Zhu S; Chang S
J Nanobiotechnology; 2022 Nov; 20(1):468. PubMed ID: 36329515
[TBL] [Abstract][Full Text] [Related]
12. Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation.
Zheng J; Sun Y; Long T; Yuan D; Yue S; Zhang N; Yang Z
Drug Deliv; 2022 Dec; 29(1):1164-1175. PubMed ID: 35393920
[TBL] [Abstract][Full Text] [Related]
13. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
[TBL] [Abstract][Full Text] [Related]
14. NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death.
Huang Y; Wei D; Wang B; Tang D; Cheng A; Xiao S; Yu Y; Huang W
Acta Biomater; 2023 Apr; 160():198-210. PubMed ID: 36792048
[TBL] [Abstract][Full Text] [Related]
15. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy.
He C; Duan X; Guo N; Chan C; Poon C; Weichselbaum RR; Lin W
Nat Commun; 2016 Aug; 7():12499. PubMed ID: 27530650
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.
Park SJ; Ye W; Xiao R; Silvin C; Padget M; Hodge JW; Van Waes C; Schmitt NC
Oral Oncol; 2019 Aug; 95():127-135. PubMed ID: 31345380
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
18. CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer.
Li Y; Zhang H; Li Q; Zou P; Huang X; Wu C; Tan L
Cancer Lett; 2020 Dec; 495():12-21. PubMed ID: 32941949
[TBL] [Abstract][Full Text] [Related]
19. Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment.
Wen Y; Chen X; Zhu X; Gong Y; Yuan G; Qin X; Liu J
ACS Appl Mater Interfaces; 2019 Nov; 11(46):43393-43408. PubMed ID: 31701733
[TBL] [Abstract][Full Text] [Related]
20. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
Rodríguez-Salazar MDC; Franco-Molina MA; Mendoza-Gamboa E; Martínez-Torres AC; Zapata-Benavides P; López-González JS; Coronado-Cerda EE; Alcocer-González JM; Tamez-Guerra RS; Rodríguez-Padilla C
Oncol Lett; 2017 Jul; 14(1):844-852. PubMed ID: 28693241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]